• Start
  • Cancer
  • Technology
    • Technology
    • Human Scaffolds
    • 3D Synthetic Scaffolds
  • Products & Services
  • Pipeline
  • News
  • Publications
  • Partners & Customers
  • About
Curing cancer by generating precision medicine Curing cancer by generating precision medicine Curing cancer by generating precision medicine Curing cancer by generating precision medicine
  • Start
  • Cancer
  • Technology
    • Technology
    • Human Scaffolds
    • 3D Synthetic Scaffolds
  • Products & Services
  • Pipeline
  • News
  • Publications
  • Partners & Customers
  • About

Archives

Monthly Archive for: "September, 2021"
Home » Archives for September 2021
8. 3D printed nanocellulose scaffolds as a cancer cell culture model system
 0
By Per Setterberg
In Publication
Posted September 13, 2021

8. 3D printed nanocellulose scaffolds as a cancer cell culture model system

8.-3d-printed-nanocellulose-scaffolds-as-a-cancer-cell-culture-model-system

READ MORE
7. Patient-derived scaffolds as a drug-testing platform for endocrine therapies
 0
By Per Setterberg
In Publication
Posted September 13, 2021

7. Patient-derived scaffolds as a drug-testing platform for endocrine therapies

7.-patientderived-scaffolds-as-a-drugtesting-platform-for-endocrine-therapies-in-breast-cancer

READ MORE
Recent Posts
  • Business Developer
    Business Developer
    May 1, 2024
  • Iscaffpharma’s first patent issued by the United States Patent and Trademark Office
    Iscaffpharma’s first patent issued by the United States Patent and Trademark Office
    January 26, 2024
  • SLAS honors Per Setterberg as fellow member
    SLAS honors Per Setterberg as fellow member
    October 19, 2023
Recent Publications
  • 16. Deciphering the role of FUS::DDIT3 expression and tumor microenvironment in myxoid liposarcoma development
    16. Deciphering the role of FUS::DDIT3 expression and tumor microenvironment in myxoid liposarcoma development
    April 26, 2024
  • 15. Proteomics of cell-free breast cancer scaffolds identify clinically relevant imprinted proteins and cancer-progressing properties
    15. Proteomics of cell-free breast cancer scaffolds identify clinically relevant imprinted proteins and cancer-progressing properties
    April 4, 2024
  • 14. Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features
    14. Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features
    January 3, 2024
Contact us
  • Org nr: 559120-9753
  • Iscaff Pharma AB
    Erik Dahlbergsgatan 11A
    411 26 Gothenburg
    Sweden
  • contact@iscaffpharma.com
Copyright All Rights Reserved © 2023
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt